eCTD Submission Challenges
Industry standards are continually evolving, creating an environment of rapid change. With change comes challenges.…
Certara2022 年 6 月 1 日
PK Modeling Supports Dosing Strategy for Patients with Hepatic Impairment
Primary biliary cholangitis (PBC) is a chronic disease that impedes bile flow from the liver,…
Certara2022 年 5 月 31 日
Learn how to shorten the drug discovery design-make-test-analyze cycle with D360
Researchers use D360 to query research data efficiently across different data sources and to create…
Certara2022 年 5 月 25 日
The utility of model-informed drug development for rare diseases
Model-informed drug development (MIDD) is a network of closely integrated ecosystems that can seamlessly position…
Certara2022 年 5 月 20 日
Certara Earns 2022 Great Place to Work Certification™
Princeton, NJ, 2022 年 5 月 17 日. Certara, Inc., a global leader in biosimulation, today announced that…
Certara2022 年 5 月 17 日
Ask Me Anything: Career Opportunities in Regulatory & Medical Writing
Have you ever wondered what it would be like to be a Regulatory or Medical…
Certara2022 年 5 月 12 日
Approaches to Address the Regulatory Requirements for System Qualification of the Simcyp Simulator
Physiologically-based pharmacokinetic (PBPK) modeling is being increasingly used in drug development to avoid unnecessary clinical…
Certara2022 年 5 月 9 日
P21 Adds Support for CDISC Open Rules Engine (CORE)
P21 is proud to announce that support for CDISC Open Rules Engine (CORE) is now available…
Certara2022 年 4 月 25 日
